InnovoTEX Inc. — SEC Form D Filing

InnovoTEX Inc. filed an SEC Form D on August 6, 2026, reporting $750K raised in Pharmaceuticals.

Form D filing details

Filing
SEC Form D
Filing date
August 6, 2026
Amount reported
$750K
Round stage
Seed
Industry
Pharmaceuticals
Website
https://innovotex.com

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Pharmaceutical companies struggle with inefficient and costly textile-based manufacturing processes that can compromise product quality and safety.

Solution

InnovoTEX Inc. provides advanced, innovative textile-based materials and solutions specifically engineered to optimize pharmaceutical manufacturing, ensuring higher quality and reduced operational costs.

Why now

The specific timing catalyst is unclear from available information.

Source: SEC EDGAR Form D filing